• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Hemorrhage/Bleeding (1888); Low Blood Pressure/ Hypotension (1914)
Event Date 12/09/2021
Event Type  Injury  
Manufacturer Narrative
A replacement product was sent.The test strips were requested but will not be available as they were all used up.The reporter's meter was provided for investigation where it was tested using retention strips and retention controls.Testing results (qc range = 2.4 - 3.6 inr): qc 1: (b)(4) inr.Qc 2: (b)(4) inr, qc 3: (b)(4) inr.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.All measurements were without error messages.The results alleged by the customer were observed in the meter¿s patient result memory.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.The investigation did not identify a product problem.The cause of the event could not be determined.The reporter is the patient's wife.
 
Event Description
We received an allegation of questionable inr results from a coaguchek xs meter with serial number (b)(4) that led to a bleeding event requiring blood transfusion and hospitalization.On (b)(6) 2021, the patient was reported to have undergone cholecystectomy after being diagnosed with gallstone pancreatitis.On (b)(6) 2021 at 9:16 am, the meter result was 2.5 inr.It was reported that the patient's warfarin dosage was changed based on this meter result.No details were provided on the actual changes made.On the same day, the reporter stated that the patient developed right-sided pain and did not feel well.His blood pressure was taken but a result was not obtained.It was assumed that the blood pressure "was too low to read".The patient was then brought to the emergency room.The laboratory result at 3:45 pm was reportedly 3.3 inr.The patient was reportedly hospitalized for one week and suffered a lot of blood loss due to internal bleeding.Oozing was reportedly noted on the gallbladder surgery site.Warfarin was put on hold and the patient was given intravenous vitamin k.He also reportedly required multiple blood transfusions (5 to 10 units).The reporter stated that the patient's inr was monitored through laboratory testing.The reporter states that the physician felt that the warfarin was a factor in the patient developing internal bleeding.The patient's overall health was reported to be fair.The patient's current condition was described to be "still dealing with pain." his condition is being monitored at home.The therapeutic range is 2.0 - 3.0 inr and testing is performed every two weeks.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key13367656
MDR Text Key284881898
Report Number1823260-2022-00221
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 01/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/27/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number04625374160
Device Lot NumberASKU
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/13/2022
Date Manufacturer Received12/30/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
LAMOTRIGINE; METOPROLOL; SODIUM; WARFARIN
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age56 YR
Patient SexMale
-
-